Ginkgo Bioworks Holdings, Inc (DNA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jason Kelly
Employees:
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
(877) 442-5362

Ginkgo Bioworks, Inc. operates as an organi® company that develops a cell programming platform to automate the process of designing, building, and testing genetic programs. It focuses on strain improvement, enzyme discovery, new product development, biosecurity, and mammalian cell engineering areas. The company was incorporated in 2008 and is based in Boston, Massachusetts.

View SEC Filings from DNA instead.

View recent insider trading info

Funds Holding DNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KELLY JASON R SEE REMARKS

  • Officer
  • Director
82,581,106 2021-12-06 1

SHETTY RESHMA P. SEE REMARKS

  • Officer
  • Director
  • 10% Owner
153,210,648 2021-12-06 1

CANTON BARRY

  • 10% Owner
153,410,648 2021-12-06 1

KEWALRAMANI RESHMA

  • Director
9,818 2021-11-19 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SHETTY RESHMA P. - Director - Officer - > 10% Owner SEE REMARKS by bartholomew canton living trust

2021-12-08 20:06:46 -0500 2021-12-07 G 200,000 d 0 indirect 1.82 5.9656 9.7068 5 -3.9434 4

CANTON BARRY - > 10% Owner by bartholomew canton living trust

2021-12-08 20:06:55 -0500 2021-12-07 G 200,000 d 0 indirect 1.82 5.9656 9.7068 5 -3.9434 4

KELLY JASON R - Director - Officer SEE REMARKS

2021-12-08 20:07:06 -0500 2021-12-07 G 150,000 d 0 direct 1.82 5.9656 9.7068 5 -3.9434 4

SHETTY RESHMA P. - Director - Officer - > 10% Owner SEE REMARKS by bartholomew canton living trust

2021-12-08 20:06:46 -0500 2021-12-06 C 200,000 a 200,000 indirect 1.82 5.9656 9.7068 5 -3.9434 4

CANTON BARRY - > 10% Owner by bartholomew canton living trust

2021-12-08 20:06:55 -0500 2021-12-06 C 200,000 a 200,000 indirect 1.82 5.9656 9.7068 5 -3.9434 4

KELLY JASON R - Director - Officer SEE REMARKS

2021-12-08 20:07:06 -0500 2021-12-06 C 150,000 a 150,000 direct 1.82 5.9656 9.7068 5 -3.9434 4

CANTON BARRY - > 10% Owner by bartholomew canton living trust

2021-12-08 20:06:55 -0500 2021-12-06 C 200,000 d 70,189,783 indirect

KELLY JASON R - Director - Officer SEE REMARKS

2021-12-08 20:07:06 -0500 2021-12-06 C 150,000 d 70,703,049 direct

SHETTY RESHMA P. - Director - Officer - > 10% Owner SEE REMARKS by bartholomew canton living trust

2021-12-08 20:06:46 -0500 2021-12-05 C 200,000 d 70,189,783 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 22:15:03 UTC -4.6865 4.7565 800
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 21:45:03 UTC -4.6865 4.7565 1000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 21:15:03 UTC -4.6865 4.7565 1000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 20:15:03 UTC -4.6884 4.7584 10000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 19:45:03 UTC -4.6884 4.7584 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 19:15:03 UTC -4.6884 4.7584 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 18:45:03 UTC -4.0835 4.1535 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 18:15:03 UTC -4.0835 4.1535 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 17:45:03 UTC -4.0835 4.1535 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 17:15:03 UTC -4.0835 4.1535 45000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 16:45:03 UTC -4.1447 4.2147 45000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 16:15:03 UTC -4.1447 4.2147 45000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 15:45:03 UTC -4.1447 4.2147 50000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 15:15:03 UTC -4.1447 4.2147 55000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 14:45:03 UTC -4.1447 4.2147 60000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 14:15:03 UTC -4.1447 4.2147 65000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 13:45:03 UTC -5.008 5.078 65000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 13:15:03 UTC -5.008 5.078 65000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-21 12:45:03 UTC -5.008 5.078 55000
GINKGO BIOWORKS HOLDINGS INC DNA 2022-01-20 22:15:03 UTC -5.0117 5.0817 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments